Vaccine protection against Zika virus from Brazil

Rafael A. Larocca, Peter Abbink, Jean Pierre Schatzmann Peron, +23

Nature

VaccinationVaccine SafetyVaccine DevelopmentVirologyMedicine +2

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Peter Abbink, Rafael A. Larocca, Rafael A. De La Barrera, +35

Science

VaccinationVaccine SafetyProtective EfficacyVaccine DevelopmentPlasmid Dna Vaccine +10

Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys

Malika Aïd, Peter Abbink, Rafael A. Larocca, +18

Cell

Rhesus MonkeysNeuroanatomyNeuroinfectious DiseasesNeurovirologyViral Pathogenesis +11

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Kayvon Modjarrad, Leyi Lin, Sarah L. George, +34

The Lancet

VaccinationVaccine SafetyVaccinologyVaccine TrialPlacebo-controlled Clinical Trials +5

Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys

Amanda J. Martinot, Peter Abbink, Onur Afacan, +15

Cell

Maternal ImmunizationFetal NeuropathologyNeurovirologyNeuroscienceFetal Complication +3

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys

Peter Abbink, Rafael A. Larocca, Kittipos Visitsunthorn, +23

Science Translational Medicine

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

Vincent Dussupt, Rajeshwer S. Sankhala, Gregory D. Gromowski, +49

Nature Medicine

VaccinationVaccine TargetImmunologyPotent ZikaVirology +6

A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

Nadine C. Salisch, Kathryn E. Stephenson, Kristi L. Williams, +21

Annals of Internal Medicine

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

Kathryn E. Stephenson, Chen Sabrina Tan, Stephen R. Walsh, +23

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentImmunology +8

Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR−/− Mice

Rafael A. Larocca, Érica Araújo Mendes, Peter Abbink, +11

Cell Host & Microbe

VaccinationMaternal ImmunizationVaccine DevelopmentImmunologyVirology +7